[Clinical aspects and treatment of invasive meningococcal infections]

Perrine Parize1

  • 1Service des maladies infectieuses et tropicales, centre d'infectiologie, hôpital Necker, Paris, France.

La Revue Du Praticien
|December 5, 2018
PubMed

Insights

Invasive meningococcal infections can be severe, but early treatment improves outcomes. Meningococcal sepsis and purpura fulminans remain high-risk, necessitating updated diagnostic and management strategies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Meningococcus is a common human bacterium residing in the upper respiratory tract.
  • Invasive meningococcal infections can lead to severe diseases, including sepsis and purpura fulminans.
  • While overall mortality has decreased due to medical advancements, case fatality for severe forms remains high.

Purpose of the Study:

  • To detail diagnostic strategies for suspected meningococcal disease.
  • To outline current management approaches for invasive meningococcal infections.
  • To summarize French Public Health Department guidelines on chemoprophylaxis and cluster management.

Main Methods:

  • Review of clinical aspects and treatment of invasive meningococcal infections.
  • Analysis of diagnostic and management protocols.
  • Summary of updated public health guidelines.

Main Results:

  • Antimicrobial agents, intensive care, and pre-admission antibiotics have reduced overall mortality.
  • Meningococcal sepsis and purpura fulminans continue to present high, stable case fatality rates.
  • Severe neurological and functional sequelae are common in survivors.

Conclusions:

  • Prompt diagnosis and management are crucial for improving outcomes in meningococcal disease.
  • Despite advances, severe forms of meningococcal infection pose significant risks.
  • Adherence to updated guidelines for chemoprophylaxis and cluster management is essential for public health.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
514
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.8K
Nursing Clinical Information System01:27

Nursing Clinical Information System

Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.3K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.5K
Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
12.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K